Literature DB >> 1353946

Malignant fibrous histiocytoma. Proliferative compartment and heterogeneity of "histiocytic" cells.

H Iwasaki1, K Yoshitake, Y Ohjimi, M Kikuchi, T Isayama, S Yoh, N Shinohara, M Enjoji.   

Abstract

To elucidate the precise origin and characteristics of the proliferating cells in malignant fibrous histiocytoma (MFH), the authors analyzed 33 MFH tumors, using immunohistochemical techniques with a panel of 12 antibodies. All three types of MFH cells (spindle cells, polygonal cells, and bizarre giant cells) stained positively for mesenchymal antigens (FU3 and vimentin) but did not stain for macrophage/histiocyte markers (HAM 56 and CD68). Therefore, the MFH cells may not represent true histiocytes, although they may be mesenchymal-derived cells behaving as "facultative histiocytes" with superficial resemblance to actual histiocytes. Normal histiocytes in the stroma tested positive for macrophage/histiocyte antigens; the most common cells were HAM 56-positive cells constituting 30-80% of nonneoplastic stromal cells, followed by those positive for CD68 (10-50%), Mac 387 (less than 2%), and S-100 protein (less than 1%). Our results indicate the presence of heterogeneity of "histiocytic" cells in MFH. Proliferating-cell nuclear antigen (PCNA) was expressed not only in the spindle and polygonal MFH cells but also in the bizarre giant cells. These findings suggest that all three types of MFH cells participate in the proliferative compartment of MFH. Uneven PCNA staining of the irregular nuclear segments of the bizarre giant cells may result in abnormal DNA synthesis, possibly contributing to the marked diversity of nuclear morphology in MFH. Touton-type and osteoclast-like giant cells did not stain for PCNA but stained positively for histiocytic markers. Therefore, these giant cells may lack proliferative activity and probably result from normal histiocytes fusing together.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353946     DOI: 10.1097/00000478-199208000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Serial growth of human malignant fibrous histiocytoma xenografts in immunodeficient mice.

Authors:  N Kurihara; T Kubota; Y Otani; M Watanabe; K Kumai; M Kitajima
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  [Malignant fibrous histiocytoma: pleomorphic sarcoma NOS or pleomorphic fibrosarcoma].

Authors:  P Meister
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

3.  FU-3 monoclonal antibody: a specific marker for malignant fibrous histiocytoma? An analysis of 32 malignant soft tissue and bone sarcomas.

Authors:  M J Perez-Bacete; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Proliferating cell nuclear antigen staining as a prognostic indicator in soft-tissue malignant fibrous histiocytoma.

Authors:  H Sugiura; K Sato; S Yamamura; T Nagasaka; M Takahashi; H Katagiri
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

Review 5.  KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.

Authors:  M Cassidy; B Loftus; A Whelan; B Sabt; D Hickey; K Henry; M Leader
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.